Daiwa Securities Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Buy |
664
+40
| +6% | +$1.75K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $22K | Hold |
624
| – | – | ﹤0.01% | 1066 |
|
|
2024
Q4 | $17K | Sell |
624
-31,085
| -98% | -$847K | ﹤0.01% | 1090 |
|
|
2024
Q3 | $807K | Sell |
31,709
-4,000
| -11% | -$102K | ﹤0.01% | 767 |
|
|
2024
Q2 | $904K | Buy |
35,709
+35,059
| +5,394% | +$888K | ﹤0.01% | 724 |
|
|
2024
Q1 | $20K | Sell |
650
-61
| -9% | -$1.88K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $29K | Buy |
711
+161
| +29% | +$6.57K | ﹤0.01% | 1100 |
|
|
2023
Q3 | $15K | Hold |
550
| – | – | ﹤0.01% | 1104 |
|
|
2023
Q2 | $9K | Sell |
550
-7,747
| -93% | -$127K | ﹤0.01% | 1134 |
|
|
2023
Q1 | $138K | Buy |
8,297
+1,522
| +22% | +$25.3K | ﹤0.01% | 959 |
|
|
2022
Q4 | $52K | Sell |
6,775
-2,033
| -23% | -$15.6K | ﹤0.01% | 1028 |
|
|
2022
Q3 | $88K | Buy |
8,808
+8,258
| +1,501% | +$82.5K | ﹤0.01% | 1006 |
|
|
2022
Q2 | $5K | Buy |
550
+121
| +28% | +$1.1K | ﹤0.01% | 1160 |
|
|
2022
Q1 | $4K | Hold |
429
| – | – | ﹤0.01% | 1181 |
|
|
2021
Q4 | $7K | Sell |
429
-84
| -16% | -$1.37K | ﹤0.01% | 1159 |
|
|
2021
Q3 | $24K | Buy |
513
+218
| +74% | +$10.2K | ﹤0.01% | 1089 |
|
|
2021
Q2 | $18K | Hold |
295
| – | – | ﹤0.01% | 1018 |
|
|
2021
Q1 | $18K | Buy |
295
+64
| +28% | +$3.91K | ﹤0.01% | 1014 |
|
|
2020
Q4 | $16K | Sell |
231
-466
| -67% | -$32.3K | ﹤0.01% | 989 |
|
|
2020
Q3 | $26K | Hold |
697
| – | – | ﹤0.01% | 965 |
|
|
2020
Q2 | $20K | Hold |
697
| – | – | ﹤0.01% | 1012 |
|
|
2020
Q1 | $20K | Hold |
697
| – | – | ﹤0.01% | 1000 |
|
|
2019
Q4 | $24K | Buy |
+697
| New | +$24K | ﹤0.01% | 991 |
|